This month, we replay a popular webinar on sleep disturbances -- a common non-motor symptom of Parkinson's disease that may cause difficulty falling or staying asleep. Our panelists discuss how to manage these disturbances and current research on sleep and PD.
Webinar Details
Date:
Duration:
Time:
Thank you for registering for “Your Daily Dose: Managing Parkinson’s Prescriptions” webinar.
MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.
Date of Original Release: May 18, 2017
Re-reviewed for Re-release: December 20, 2018
Date CME Credit No Longer Available: December 20, 2020Learning Objectives
- Describe sleep disorders that are commonly associated with Parkinson's disease.
- Discuss Parkinson's motor and non-motor symptoms as well as medications that can affect sleep.
- Summarize pharmacological and non-pharmacological treatments for sleep disturbances in Parkinson's.
- Recognize ongoing research in sleep and Parkinson's disease.
Target Audience
This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Oakstone Publishing, LLC designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.
Faculty
Dave Iverson
Moderator
Nothing to discloseCarlos Singer, MD
Professor of Neurology, and Director of the Divison of Parkinson's Disease and Movement Disorders
University of Miami
Nothing to discloseAleksandar Videnovic, MD
Associate Professor of Neurology, Harvard Medical School
Director, Program on Sleep, Circadin Biology and Neurodegeneration, Massachusetts General Hospital
Research-Grants: Pfizer, Sunovion, NIH, Adamas, National Parkinson Foundation, Parkinson Study Group, Lundbeck
Advisory Role: Neurocrine
Honoraria: Neurocrine, US World Meds, TEVAMichael Sweet, Sr.
Policy and Advocacy Volunteer, The Michael J. Fox Foundation
Nothing to disclose